Navigation Links
New Drug Application Submitted for Investigational Antibiotic Doripenem

RARITAN, N.J., Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for doripenem, an investigational carbapenem antibiotic for the treatment of nosocomial pneumonia, a pneumonia that is acquired in a hospital or other healthcare setting.

According to the Centers for Disease Control and Prevention (CDC), two million Americans develop hospital-acquired infections each year, and approximately 90,000 die as a result. Approximately 70 percent of these infections are resistant to at least one antibiotic. Pneumonia is the second, most-common, hospital-acquired infection in the United States and is associated with substantial morbidity and mortality.

Doripenem belongs to a class of antibacterial agents called carbapenems, which are useful in treating life-threatening infections caused by Gram-negative(1) and Gram-positive(2) bacteria. The data supporting the NDA showed doripenem was an effective treatment for hospital-acquired pneumonia. The data also demonstrated the effectiveness of doripenem against infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa and Enterobacteriaceae, including strains of these bacteria that are resistant to other therapies.

Pseudomonas aeruginosa is one of the leading causes of hospital-acquired infections and, because of increasing multi-drug resistance, treatment options are limited. In general, there are few antibiotics available or currently in development to treat the resistant infections - which can be potentially life-threatening - associated with these Gram-negative bacteria.

In clinical trials, doripenem was well-tolerated. The most common treatment-emergent adverse events seen were diarrhea, nausea, constipation, urinary tract infection and decubitus ulcer, commonly known as a bedsore.


'"/>




Page: 1

Related medicine news :

1. Prostate Cancer Can Be Treated By Application Of LASER Technology
2. Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human
3. Venus Remedies Files 5th International Patent Application
4. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
5. Recd Number of Abstracts Submitted for Sci Cong on Osteoporosis
6. Investigational Drug Being Pursued for the Treatment of Ischaemic Stroke
7. Astrazenecas Investigational Cancer Therapies Revealed at ASCO
8. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
9. Antibiotics Helps Autism
10. Antibiotics losing their power against acne
11. Antibiotic induces liver damage in children with E.COLI infections.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... September 26, 2017 , ... Data Integrity: , The Key to FDA ... 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity , Consider this situation. ... electronic records may not be trustworthy and reliable … a more detailed evaluation may ...
(Date:9/26/2017)... PA (PRWEB) , ... September 26, 2017 , ... The ... in Chicago, called “The Magic of Fat,” revealed not only the latest about cosmetic ... prove to be an evolution in cosmetic medicine. , “Fat really is magical, especially ...
(Date:9/26/2017)... ... , ... “Good Morning Sunshine!: Finding Strength and Comfort in God”: a ... Strength and Comfort in God” is the creation of published author, Terri Braun, a ... has worked at a local mental health center for over twenty years, helping the ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... “Sonflower Submission”: ... a strong-willed nature to the inevitable destinations of negativity, complaining and the need to ... side to take effect in order for a lesson in stress-less living to be ...
(Date:9/26/2017)... ... ... Time out for Daddy is a moving story of a family's unconditional ... mistakes. “Time Out for Daddy” is the creation of published author Debra Titus, who ... for children inspired her to write this book. , Published by Christian Faith Publishing, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... -- ... Washington DC ... 12 th – Monday, September 18 th .The Brain Tumor Foundation ... scans to the public.Where:  BTF,s Mobile MRI Unit ... Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/6/2017)... Sept. 6, 2017  Medical professionals are ... skills while treating their patients. Medical simulations ... without involving patients. Simulation provides a safe ... carry out procedures, refine techniques and build ... of new technology, such as augmented reality, ...
Breaking Medicine Technology: